Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re

Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4

Bimal Bhindi, Stephen A. Boorjian

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalEuropean Urology
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Cystectomy
Residual Neoplasm
Drug Therapy

ASJC Scopus subject areas

  • Urology

Cite this

@article{8dcbb3b178d84b4689552f3419c51c92,
title = "Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4",
author = "Bimal Bhindi and Boorjian, {Stephen A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.eururo.2017.10.017",
language = "English (US)",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",

}

TY - JOUR

T1 - Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re

T2 - Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4

AU - Bhindi, Bimal

AU - Boorjian, Stephen A.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85032739208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032739208&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2017.10.017

DO - 10.1016/j.eururo.2017.10.017

M3 - Article

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -